Cancel

Request a live demo presentation

One of our sales representative will call you soon


By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

We have generated thousand of leads for our happy customers

  • company
  • company
  • company
  • company
  • company
  • company
  • company
  • company

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED Inactive

Scientific & Education


Contact information


This information is available only for subscribed users

Subscribe

Financial statements of PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED

According to PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED latest financial report submitted on 2018-03-31, the company has a Cash of £474,000.00, Total-Assets of £474,000.00 while the Working-Capital is £380,000.00. Compared with the previous year, the company reported a Cash increase of 37.34%, which is an equivalent of -177000. At the same time, the Total-Assets went up by 32.28%, or by -153000.



Consolidated A/cs

For more information you can

Upgrade plan

Turnover 2018

£ 0

  • Consolidated A/cs

    Y

  • Reporting period

    12

  • Working Capital

    £ 380000

  • Profit after Tax

    £ 152000

Reporting period Full financial info

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED Business Credit Report

A Business Credit Report for PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.


Overall Credit Risk for

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED

Unlock Credit Report

For more information you can

Key features

  • Credit Score and Credit Limit
  • Financial accounts for the past 5 years
  • Credit Officers
  • Document Filing history
  • Corporate Ownership
  • Outstanding & Satisfied Mortgages
  • Shareholder Information
  • Company Identity

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED Directors and key executives

View all employees

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED currently employs 7 people.
In order to view contact information, including emails and phone numbers for all the employees working at PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.


Total Employee Count

Total employees

7

Management Level


100

Middle

×
Employee Job Title Email Phone Country
Colin Knox Director
-
- GB
Ian Kent Director
-
- GB
Harry Finch Director
-
- GB
Hugo Slootweg Director
-
- GB
Christopher Ashton Director
-
- GB

Get in touch with 7 of contacts working at PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED

Upgrade to subscription

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED Ownership and Group Structure

View full group structure

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED is a holding company that owns 3 of business within its group, including ETIOLOGICS********, PULMAGEN THERAPEUTIC*******************, PULMAGEN THERAPEUTICS*******************.


PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED Shareholders

View all shareholders

There are currently 5 people with significant control at PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED. One of of major shareholders of PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED is DAVID STEVENSON, which owns 1471 ORDINARY shares, with a total value of 1,471 GBP and JANET ANN ARCHER, which owns 7323 PREFERENCE B shares, with a total value of 7,323 GBP and ETV CAPITAL SA, which owns 70000 PREFERENCE A shares, with a total value of 70,000 GBP and PAUL MATTHEW BLANEY, which owns 3407 ORDINARY shares, with a total value of 3,407 GBP and GWEN EYRE, which owns 3307 PREFERENCE B shares, with a total value of 3,307 GBP.


Name Quantity Share Type Value
DAVID STEVENSON 1471 ORDINARY 1471 GBP
JANET ANN ARCHER 7323 PREFERENCE B 7323 GBP
ETV CAPITAL SA 70000 PREFERENCE A 70000 GBP
PAUL MATTHEW BLANEY 3407 ORDINARY 3407 GBP
GWEN EYRE 3307 PREFERENCE B 3307 GBP

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED competitors:

View all competitors

Top 5 similar companies of PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED are S&P GLOBAL HOLDINGS UK LIMITED, WELLINGTON REALISATIONS GROUP LIMITED, VERTEX GROUP LIMITED, S&W TLP (HOLD CO ONE) LIMITED, WHEELABRATOR TECHNOLOGIES (UK) LIMITED. View and export all the competitor list of PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED by upgrading your account here.


S&P GLOBAL HOLDINGS UK LIMITED


Revenue
-
Age
42 years
Employees
6
Industry
View Finance & Insurance
Website
View http://mcgraw***********

WELLINGTON REALISATIONS GROUP LIMITED


Revenue
-
Age
57 years
Employees
1
Industry
View Business Services
Website
View http://www.rely*************

VERTEX GROUP LIMITED


Revenue
-
Age
15 years
Employees
5
Industry
View Internet Services
Website
View http://vert*********

S&W TLP (HOLD CO ONE) LIMITED


Revenue
3,309,000.0
Age
13 years
Employees
7
Industry
View Industrial Development Consultants
Website
View http://www.ve************

WHEELABRATOR TECHNOLOGIES (UK) LIMITED


Revenue
-
Age
35 years
Employees
6
Industry
View Hvac Equipment
Website
View http://wtie*********

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED news & activities:

View full activity

EBITDA

The PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED-based company said the adjusted EBITDA is now -£9,000.00, compared with the previous year of 21000.

uk.globaldatabase.com

2018-03-31

Employees

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED number of employees has decreased by % compared with previous year and now represents a total number of 7.

uk.globaldatabase.com

2018-03-31

Frequently Asked Questions regarding PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED


Where is PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED registered office?

PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED is located at C/O DR C P ASHTON STEVENAGE BIOSCIENCE CATALYST, United Kingdom.

How many people work at PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED?

According to the latest account statement, there are currently 7 of employees working for PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED.

What is PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED EBITDA?

For 2018, PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED has reported an EBITDA of -£9,000.00, which went down by -333.33% compared to previous year.

What is the Business Credit Score of PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED and how reliable is the company?

In order to check the business credit score of PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.

Does PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED pay their invoices on time?

By requesting a Business Credit Report for PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED, you will be able to gain more insights about the PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED payment trends.

Who is the Ultimate Parent of the PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED?

Information about the ultimate beneficial ownership PULMAGEN THERAPEUTICS******************* of PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED is available when you order a business credit report.

Search for International Credit Report

0 results
Name
Arrow Arrow
City
Arrow Arrow
Address
Arrow Arrow
Reg. No
Arrow Arrow
Status
Arrow Arrow
Action